Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.35 USD | +3.35% | +8.66% | +188.03% |
04-29 | Cullinan Therapeutics Appoints Mary Kay Fenton as CFO | MT |
04-29 | Cullinan Therapeutics, Inc Appoints Mary Kay Fenton as Chief Financial Officer | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Bullish | Bullish |
Resistance | 35.91 | 45.73 | 33.11 |
Spread/Res. | -18.27% | -35.82% | -11.36% |
Spread/Supp. | +38.97% | +87.78% | +87.42% |
Support | 21.12 | 15.63 | 15.66 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- CGEM Stock
- Charts Cullinan Therapeutics, Inc.